Nutrition, Physical Activity, and Cognition in Breast Cancer Survivors
NCT ID: NCT02591316
Last Updated: 2016-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
68 participants
OBSERVATIONAL
2015-02-28
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The INFLUENCE of PHYSICAL ACTIVITY on the HEALTH and WELL-BEING of BREAST CANCER SURVIVORS
NCT06672380
Promoting a Healthier Lifestyle Among Breast Cancer Survivors
NCT01419613
Narrative Visualization for Breast Cancer Survivors' Physical Activity
NCT03612596
Improving Cognition After Cancer
NCT04049695
Promoting Activity in Cancer Survivors
NCT03060941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study involves two, 1hr appointments at Texas State University. The first visit will include cognitive testing and body composition assessment. Participants will be given an activity monitor to wear for one week and a packet of questionnaires to complete at home. At the second visit, a fasted blood sample will be collected, and participants will complete a food frequency questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast cancer survivor
Inclusion criteria: Female breast cancer survivors (30-70yrs of age) that have completed primary treatment (chemotherapy, radiation therapy or both) within past 60 months
no intervention
Control
Females (30-70yrs of age) with no previous cancer diagnosis.
no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age-matched controls must have no previous cancer diagnosis
* Female
* no history of stroke, heart attack or transient ischemic attack
* not currently pregnant; can speak, read, and write English
* can attend all testing sessions
* not blind or legally blind; nonsmoker
* no current use of computer-based brain training games (e.g. Lumosity ®, BrainHQ ®).
Exclusion Criteria
* \< 30 or \> 70 years of age
* breast cancer survivor \> 60 months from last treatment or currently undergoing primary treatment
* breast cancer survivor never treated with chemotherapy and/or radiation
* previous cancer diagnosis other than breast cancer
30 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Texas State University, San Marcos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Krystle Zuniga
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Krystle E Zuniga, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
Texas State University, San Marcos
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Texas State University
San Marcos, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014T34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.